Working… Menu

A First in Human Study to Assess the Safety, Tolerability and Immunogenicity of a Single Dose of a Trivalent Inactivated Poliovirus Vaccine Based on Sabin Strains (sIPV) Given Intramuscularly in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03032588
Recruitment Status : Completed
First Posted : January 26, 2017
Last Update Posted : July 8, 2019
Information provided by (Responsible Party):
Janssen Vaccines & Prevention B.V.